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Chromosome segregation and cytokinesis must be tightly coordinated to ensure that chromo-
somes are accurately partitioned between dividing cells. In this issue, Steigemann et al. (2009) 
report that Aurora B kinase promotes proper chromosome segregation by delaying abscission 
when chromatin is trapped between dividing cells.Chromosome losses and gains (aneu-
ploidy) lead to gene deregulation and 
appear to contribute to cancer progres-
sion (Torres et al., 2008). Such genomic 
changes can occur through defects in 
mitotic progression. In cultured cells, 
for example, tetraploidy can result from 
a failure of cytokinesis (Ganem et al., 
2007). Tetraploidy and the accompany-
ing gain in the number of centrosomes 
increases the potential for multipolar 
spindle formation and for inappropriate 
kinetochore-microtubule attachments 
at metaphase, both of which can lead to 
chromosome missegregation and aneu-
ploidy (Ganem et al., 2007). Steigemann 
et al. (2009) now report a mechanism 
during late cytokinesis to avert tetra-
ploidy if chromosomes become trapped 
in the canal between dividing cells. These 
chromosome bridges induce a delay in 
abscission that is dependent on Aurora 
B kinase, thus allowing time for bridge 
resolution and avoiding tetraploidy.
Cytokinesis in animal cells occurs 
after chromosome segregation through 
the initiation of furrow ingression, which 
is mediated by contraction of the acto-
myosin ring. It is completed by the physi-
cal separation of the two nascent daugh-
ter cells during abscission (Barr and 
Gruneberg, 2007). Three distinct stages 
of cytokinesis have been identified: 
membrane furrowing (early telophase), 
intercellular bridge and midbody forma-
tion and stabilization (late telophase), and 
abscission (the final events culminating 
in daughter cell separation). Abscission 
consists of a series of events occurring 
within a cytoplasmic canal between 
nascent daughter cells. These include 
microtubule destabilization and sever-
ing and several membrane-remodeling 
events (Barr and Gruneberg, 2007). In Figure 1. Cytokinesis with or without Chromosome Bridges
(Left) A cell that properly segregates chromosomes undergoes furrowing. During telophase, actin patches 
remain at the furrow and Aurora B is localized to the midbody region. At the end of cytokinesis, actin patch-
es and midbody microtubules disassemble, Aurora B kinase activity declines, and abscission occurs. 
(Right) A chromosome bridge in the intercellular canal sustains the activity of Aurora B, causing stabiliza-
tion of the canal and a delay in abscission (left). During the delay, midbody microtubules in the intercel-
lular canal disassemble but actin patches are retained. Once the chromosome bridge is resolved, Aurora 
B activity declines and abscission occurs (left). If the activity of Aurora B is inhibited before the bridge is 
resolved (right), the furrow regresses and the cell becomes tetraploid (right).Cell 136, February 6, 2009 ©2009 Elsevier Inc. 397
yeast, multiple genes are known to regu-
late mitotic exit/cytokinesis. Although 
disruption of the mammalian counter-
parts of these genes can induce abscis-
sion delay or cytokinesis failure (Bothos 
et al., 2005; Gromley et al., 2005), the 
specific cellular events being monitored 
have not been identified. In the present 
study, Gerlich and colleagues (Steige-
mann et al., 2009) identify a new surveil-
lance mechanism that monitors chroma-
tin within the intercellular canal to signal 
a delay in abscission (Figure 1).
Steigemann et al. first establish a cor-
relation between chromatin bridges in the 
intercellular canal and delayed abscis-
sion. Severing the chromatin bridges 
by laser microsurgery rapidly promotes 
abscission, suggesting that chromatin 
is the direct cause of the delay. In con-
trast, severing microtubule bundles in 
the intercellular canal has no effect on 
the timing of abscission. This suggests 
that microtubules are not required for the 
abscission delay or for intercellular canal 
stabilization as previously believed (Barr 
and Gruneberg, 2007). What then stabi-
lizes intercellular canals in the absence 
of microtubules?
One of the most compelling results 
in this paper is the retention of actin 
patches at the intercellular canal after 
completion of acto-myosin ring con-
striction. It is interesting to note that 
this distribution of actin is reminiscent 
of specialized intercellular canals that 
become stabilized in certain cellular 
contexts, namely ring canals between 
nurse cells and the oocyte in Drosophila 
embryos and intercellular bridges that 
interconnect spermatocytes to form 
multicellular syncytia in human testes 
(Robinson and Cooley, 1996). Genes 
required for assembly and function of 
these specialized stable canals may 
provide insights into the stabilization of 
intercellular canals during conventional 
cell divisions.
Steigemann et al. reasoned that Aurora 
B might serve as a sensor of chromatin 
within intercellular canals, based on the 
role of Ipl1 (the budding yeast homolog 
of Aurora) in regulating abscission tim-
ing in the NoCut pathway. This pathway 
delays cytokinesis in the presence of 
spindle-midzone defects that impede 
proper chromosome segregation (Nor-
den et al., 2006). Consistent with the 398 Cell 136, February 6, 2009 ©2009 Elsevroles of Aurora B observed in yeast, 
pharmacologic inhibition of Aurora B in 
control cultured human cells induces 
premature abscission, demonstrating a 
role for the kinase in abscission timing. 
In contrast, inhibition of Aurora B in cells 
with chromosome bridges causes furrow 
regression and tetraploidy, demonstrat-
ing that intercellular canals are destabi-
lized in the absence of kinase activity. As 
expected for the proposed mechanism 
of chromatin sensing, Aurora B is able 
to access chromatin in the intercellular 
canal despite the presence of the nuclear 
envelope.
Based on these results, the authors 
propose that the presence of a chro-
mosome bridge sustains the activity of 
Aurora B allowing phosphorylation of 
its downstream effectors. Phosphoryla-
tion of downstream targets and reten-
tion of actin patches at the intercellular 
canal would help stabilize the canal until 
the chromosome bridge is resolved and 
Aurora B activity is turned off. Chro-
mosome bridges not accompanied by 
Aurora B activation would lead to furrow 
regression and tetraploidy.
Future studies are required to eluci-
date the mechanism that leads to sta-
bilization of intercellular canals and to 
identify downstream targets of Aurora B 
that participate in this event. Steigemann 
et al. show that Aurora B phosphorylates 
mitotic kinesin-like protein 1 (Mklp1) on 
the same site critical for sequestering 
Mklp1 away from the midbody ring (Neef 
et al., 2006). However, the mechanism by 
which this phosphorylation event con-
tributes to canal stabilization remains 
uncertain. The authors also show that 
retention of actin patches is induced in 
cells with chromosome bridges, sug-
gesting that actin contributes to canal 
stabilization. Consistent with this notion 
but not yet tested is the observation that 
the long isoform of Mklp1 possesses an 
actin-binding domain and thus has the 
potential to participate in actin patch 
retention at this site (Kuriyama et al., 
2002).
Additional studies will be required to 
understand how events described by 
Steigemann et al. impact the numerous 
pathways of vesicle transport and mem-
brane remodeling involved in abscission 
(Barr and Gruneberg, 2007). The current 
data indicate that abscission is normally ier Inc.coupled with disassembly of midbody 
microtubules approximately 3 hr after 
the onset of anaphase. The presence 
of chromosome bridges uncouples 
these events and causes stabiliza-
tion of intercellular canals. This raises 
several questions. Do chromosome 
bridges affect the distribution or func-
tion of membrane transport pathways? 
If so, would alteration of these path-
ways affect the timing of abscission? 
Do membrane-associated pathways 
contribute to bridge stabilization? It will 
be interesting to determine why the tim-
ing of abscission observed by Steige-
mann et al. is more rapid than in most 
other studies. One explanation for this 
is the use of different assays to monitor 
abscission. Steigemann et al. analyzed 
the transfer of fluorescence proteins 
between cells, whereas other studies 
used phase-contrast imaging to assess 
intercellular canal cleavage.
A relevant question beyond the scope 
of this study is whether the two daughter 
cells connected by chromosome bridges 
are euploid after the bridge is resolved 
by the proposed mechanism. It will also 
be interesting to determine the fates of 
cells with chromosome bridges and 
stabilized intercellular canals. Do they 
become apoptotic, acquire chromosome 
fragments, arrest in interphase, progress 
through subsequent cell divisions, or 
become tetraploid (like cells with bridges 
that are not stabilized)?
In conclusion, the work by Steige-
mann et al. uncovers a mechanism to 
avert the generation of tetraploid cells, 
which are predisposed to aneuploidy 
and tumor progression. The center-
piece of the mechanism is detection 
of chromatin in the intercellular canal 
during abscission by Aurora B, lead-
ing to stabilization of the canal and 
delayed abscission. Accordingly, this 
work defines a new regulatory mecha-
nism for abscission in animal cells that 
prevents tetraploidization in response 
to defects in chromosome segregation. 
Because abscission is the final step in 
the process of cell division, this is the 
last chance to salvage renegade chro-
mosomes and maintain genomic integ-
rity. As with other new observations, the 
work in this paper generates a number 
of intriguing questions for future stud-
ies.
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(TORC1) is a highly conserved serine/
threonine kinase that in mammals acti-
vates cell growth in response to nutri-
ents (amino acids), growth factors (such 
as insulin and insulin-like growth fac-
tor), and cellular energy status (ATP) (for 
review, see Wullschleger et al., 2006). 
Although the signaling cascades lead-
ing from growth factors and energy 
to mTORC1 activation are known, the 
pathway that leads from amino acids to 
mTORC1 activation is less clear. Nick-
lin et al. (2009) now close a gap in our 
understanding of this pathway by iden-
tifying amino acid transporters that act 
upstream of mTORC1.
Multiple pathways converge on 
mTORC1, making it a focal point for the 
control of cell growth. Insulin and other 
growth factors activate mTORC1 by 
inhibiting the tuberous sclerosis complex 
(TSC1-TSC2) downstream of AKT (also 
known as PKB) (Figure 1). TSC1-TSC2 
is a GTPase-activating protein (GAP) for 
the small GTPase Rheb, the direct acti-
vator of mTORC1. Conversely, mTORC1 
activity is decreased in response to a 
reduction in ATP levels because of the 
activation of adenosine monophosphate 
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activated protein kinase (AMPK), which 
phosphorylates and activates TSC1-
TSC2. However, not all pathways for 
mTORC1 activation go through TSC1-
TSC2. AMPK also phosphorylates and 
inactivates mTORC1 directly. It has also 
been recently shown that amino acids 
signal to mTORC1 through heterodimers 
of Rag GTPases (RagA or B and RagC 
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or D), which deliver mTORC1 to GTP-
loaded Rheb (Kim et al., 2008; Sancak 
et al., 2008).
Amino acid availability, in particular 
the availability of the essential amino 
acids leucine and arginine, is required 
for mTORC1 activation (for review, see 
Avruch et al., 2008). The absence of leu-
cine or arginine prevents mTORC1 acti-
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